XORTX Therapeutics Says Published Research Supports Company Approach to Gout Treatment [Yahoo! Finance]
XORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update [Canadian Business Journal (Canada)]
XORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update [Yahoo! Finance]
XORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update
XORTX Announces Closing of US$1.1 Million Registered Direct Offering [Canadian Business Journal (Canada)]